Article
KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.
Human immunology - 1 Sept 2012
Wiśniewski Andrzej, Jankowska Renata, Passowicz-Muszyńska Ewa, Wiśniewska Elżbieta, Majorczyk Edyta, Nowak Izabela, Frydecka Irena, Kuśnierczyk Piotr
Abstract excerpt
Non-small cell lung carcinoma (NSCLC) is a multifactorial disease influenced by both environmental and genetic factors. Here, we examined whether the repertoire of genes encoding killer immunoglobulin-like receptors (KIR) and genes for their ligands, C1/C2 and Bw4, may affect a susceptibility to NSCLC and response to treatment. We typed 269 NSCLC patients and 690 healthy control individuals for KIR genes and for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
